Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-01-29Effect of Single Dose Intranasal Insulin on Cognitive Function in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-29A Randomized, Double-Blind, Risperidone-Reference, Parallel-Group, Safety, and Tolerability Study of Vabicaserin (SCA-136) in Japanese Subjects With Acute Exacerbation of Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-28A Placebo-Controlled, Cross-Over Trial of Aripiprazole Added to Obese Olanzapine-Treated Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-28An Open Label Trial of Ziprasidone as an Adjuvant for Clozapine- or Olanzapine-Associated Diabetes Mellitus or Impaired Fasting Glucose in Chronic Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-24Clinical and Computational Studies of Dopamine Function in Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-24Transcranial Magnetic Stimulation Guided by Neuroimaging for Patients With Persistent "Voices"
-
CLINICAL_TRIALS study record update · 2013-01-21Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-21A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-21A Phase 1, Randomized, Double-blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending, Multiple Oral Doses of SPD489 (Lisdexamfetamine Dimesylate) in Clinically Stable Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-16Motivating Persons With Schizophrenia to Exercise
-
CLINICAL_TRIALS study record update · 2013-01-16In the Cantons Graubunden and Glarus as Well as in the Principality of Liechtenstein: Influence of Intensive Outpatient Treatment of People With Schizophrenia and Schizoaffective Disorder on Quality of Life and Adherence
-
CLINICAL_TRIALS study record update · 2013-01-16L-Carnosine, an Antioxidant and AGE Inhibitor (Advanced Glycation End Products) for Cognitive Enhancement Among Persons With Schizophrenia: A Randomized, Add-on Double-Blind, Placebo Controlled, Clinical Trial
-
CLINICAL_TRIALS study record update · 2013-01-08Naltrexone Treatment of Alcohol Abuse in Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-08A 3 Weeks Open Label Study to Evaluate the Efficacy in Agitation and Safety of Quetiapine Fumarate XR in Treatment of Patients With Acute Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-04A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 3b Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets Compared With Placebo in Adolescents With Schizophrenia (Abbreviated)
-
CLINICAL_TRIALS study record update · 2013-01-04A 1-year, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Phase 3 Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Sustained-release Quetiapine Fumarate (SEROQUEL) or Placebo (Abbreviated)
-
CLINICAL_TRIALS study record update · 2013-01-04ClinicalTrials.gov study NCT00034905
-
CLINICAL_TRIALS study record update · 2013-01-04Seroquel on Glucose Metabolism
-
CLINICAL_TRIALS study record update · 2013-01-04Efficacy and Tolerability of Olanzapine, Quetiapine and Risperidone in the Treatment of First Episode Psychosis: A Randomized Double Blind 52-Week Comparison
-
CLINICAL_TRIALS study record update · 2013-01-04A 12-week International, Multicenter, Open Label, Non-comparative Study to Evaluate the Feasibility of Switching Any Antipsychotic Treatment to Sustained-release Quetiapine Fumarate (SEROQUEL®) in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2013-01-046-week Multicenter, Double-blind, Randomized, Parallel-group, Phase 3 Study to Evaluate the Feasibility of Switching From Immediate-release Quetiapine Fumarate (SEROQUEL) to Sustained-release Quetiapine Fumarate in Outpatients With Schizophrenia (Abbreviated)
-
CLINICAL_TRIALS study record update · 2013-01-03Metabolic Signatures and Biomarkers in First Episode and Recurrent Patients With Schizophrenia in Comparison to Healthy Controls
-
CLINICAL_TRIALS study record update · 2012-12-27Department of Psychiatry of NTUH Yun-Lin Branch
-
CLINICAL_TRIALS study record update · 2012-12-24An Open-Label, Drug-Drug Interaction Study Between Steady-State Valproic Acid and Single-Dose Paliperidone Extended-Release in Healthy Men
-
CLINICAL_TRIALS study record update · 2012-12-21A Sequential Groups, Open Label, Rising Multiple Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder